BUSINESS BRIEF
Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.
Business Divisions
Therapeutic Drugs MnfctingProducts & Services
Therapeutic Drugs, R&D, Custom SynthesisProposal
Industry
Pharmaceuticals
Sub Industry
Bulk Drug manufacturing
Open For Dilution
49 %
Top Customer
Ask
INR 35 Cr
Business Operation Information
Financial Information |
2020 (in INR Cr) | 2019 (in INR Cr) | 2018 (in INR Cr) | 2017 (in INR Cr) |
---|---|---|---|---|
Sales |
N.D | N.D | N.D | N.D |
EBITDA |
N.D | N.D | N.D | N.D |
PAT |
N.D | N.D | N.D | N.D |